NCT04263610 Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy Status COMPLETED Phase PHASE4
NCT04239859 Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis Status NOT_YET_RECRUITING Phase PHASE4
NCT04237116 A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) Status TERMINATED Phase PHASE3
NCT04229836 Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE) Status COMPLETED Phase PHASE4
NCT04203693 Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice Status COMPLETED Phase N/A
NCT04173637 Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04172233 A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE1/PHASE2
NCT04163016 A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) Status COMPLETED Phase PHASE1
NCT04128007 Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis Status COMPLETED Phase PHASE2
NCT04121143 A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults Status SUSPENDED Phase PHASE2
NCT04102007 A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab Status COMPLETED Phase PHASE3
NCT04080206 A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04053881 A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice Status COMPLETED Phase N/A
NCT04053387 Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) Status COMPLETED Phase PHASE3
NCT04042103 Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT04036188 Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis Status RECRUITING Phase EARLY_PHASE1
NCT04031027 A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice Status COMPLETED Phase N/A
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Status COMPLETED Phase PHASE1
NCT03992261 Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis Status COMPLETED Phase PHASE4